Andrew R.  Neill net worth and biography

Andrew Neill Biography and Net Worth

Andrew has served as our Chief Financial Officer since March 2021. He previously served as our Vice President of Finance and Corporate Strategy from July 2020 to March 2021 and as our Vice President of Corporate Development and Strategy from May 2017 to July 2020. Andrew joined Shattuck Labs in 2017 and brings over 10 years of biotechnology company management experience. Previously, Andrew was the co-founder of Lumos Pharma, a biopharmaceutical company focused on developing therapeutics for genetic rare diseases. Andrew holds an M.B.A, with majors in Health Care Management and Finance, from The Wharton School at the University of Pennsylvania, where he was a Kaiser Fellow. Andrew holds a Bachelor of Business Administration from Texas Christian University.

What is Andrew R. Neill's net worth?

The estimated net worth of Andrew R. Neill is at least $1.61 million as of January 10th, 2024. Mr. Neill owns 173,446 shares of Shattuck Labs stock worth more than $1,613,048 as of April 23rd. This net worth evaluation does not reflect any other investments that Mr. Neill may own. Learn More about Andrew R. Neill's net worth.

How old is Andrew R. Neill?

Mr. Neill is currently 38 years old. There are 4 older executives and no younger executives at Shattuck Labs. The oldest executive at Shattuck Labs is Dr. Arundathy Nirmalini Pandite M.B.A., M.D., Chief Medical Officer, who is 64 years old. Learn More on Andrew R. Neill's age.

How do I contact Andrew R. Neill?

The corporate mailing address for Mr. Neill and other Shattuck Labs executives is , , . Shattuck Labs can also be reached via phone at 512-900-4690 and via email at [email protected]. Learn More on Andrew R. Neill's contact information.

Has Andrew R. Neill been buying or selling shares of Shattuck Labs?

Andrew R. Neill has not been actively trading shares of Shattuck Labs within the last three months. Most recently, Andrew R. Neill sold 25,000 shares of the business's stock in a transaction on Wednesday, January 10th. The shares were sold at an average price of $10.00, for a transaction totalling $250,000.00. Following the completion of the sale, the chief financial officer now directly owns 173,446 shares of the company's stock, valued at $1,734,460. Learn More on Andrew R. Neill's trading history.

Who are Shattuck Labs' active insiders?

Shattuck Labs' insider roster includes Tyler Brous (Director), Josiah Hornblower (Director), Andrew Neill (CFO), Taylor Schreiber (CEO), and Erin Thomson (General Counsel). Learn More on Shattuck Labs' active insiders.

Are insiders buying or selling shares of Shattuck Labs?

In the last twelve months, insiders at the sold shares 2 times. They sold a total of 41,004 shares worth more than $418,522.12. The most recent insider tranaction occured on March, 6th when insider Stephen Stout sold 16,004 shares worth more than $168,522.12. Insiders at Shattuck Labs own 9.5% of the company. Learn More about insider trades at Shattuck Labs.

Information on this page was last updated on 3/6/2024.

Andrew R. Neill Insider Trading History at Shattuck Labs

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/10/2024Sell25,000$10.00$250,000.00173,446View SEC Filing Icon  
7/15/2021Sell2,000$22.13$44,260.00View SEC Filing Icon  
6/15/2021Sell2,000$27.53$55,060.0055,963View SEC Filing Icon  
5/17/2021Sell2,000$26.27$52,540.0057,963View SEC Filing Icon  
4/28/2021Sell20,000$35.00$700,000.0051,103View SEC Filing Icon  
4/15/2021Sell24,000$30.74$737,760.0071,103View SEC Filing Icon  
See Full Table

Andrew R. Neill Buying and Selling Activity at Shattuck Labs

This chart shows Andrew R Neill's buying and selling at Shattuck Labs by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Shattuck Labs Company Overview

Shattuck Labs logo
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. Shattuck Labs, Inc. was incorporated in 2016 and is headquartered in Austin, Texas.
Read More

Today's Range

Now: $9.48
Low: $9.23
High: $9.50

50 Day Range

MA: $9.17
Low: $8.27
High: $10.13

2 Week Range

Now: $9.48
Low: $1.33
High: $11.11

Volume

21,252 shs

Average Volume

360,673 shs

Market Capitalization

$450.02 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.11